-
1
-
-
0030051805
-
Identification of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factors
-
Campbell, W. B., Gebremedhin, D., Pratt, P. F., and Harder, D. R. (1996). Identification of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factors. Circ. Res. 78, 415-423.
-
(1996)
Circ. Res.
, vol.78
, pp. 415-423
-
-
Campbell, W.B.1
Gebremedhin, D.2
Pratt, P.F.3
Harder, D.R.4
-
2
-
-
33846414370
-
2 + -activated K + channels contribute to 11 12-epoxyeicosatrienoic acid analog mediated mesenteric arterial relaxation
-
2 + -activated K + channels contribute to 11,12-epoxyeicosatrienoic acid analog mediated mesenteric arterial relaxation. Prostaglandins Other Lipid Mediat. 83, 50-61.
-
(2007)
Prostaglandins Other Lipid Mediat
, vol.83
, pp. 50-61
-
-
Dimitropoulou, C.1
West, L.2
Field, M.B.3
White, R.E.4
Reddy, L.M.5
Falck, J.R.6
Imig, J.D.7
-
3
-
-
69049118113
-
14 15-Epoxyeicosa-5,8,11-trienoic acid (14 15-EET) surrogates containing epoxide bioisosteres: influence upon vascular relaxation and soluble epoxide hydrolase inhibition
-
Falck, J. R., Kodela, R., Manne, R., Atcha, R., Puli, N., Dubasi, N., Manthati, V. L., Capdevila, J. H., Yi, X. Y., Goldman, D. H., Morisseau, C., Hammock, B. D., and Campbell, W. B. (2009). 14,15-Epoxyeicosa-5,8,11-trienoic acid (14,15-EET) surrogates containing epoxide bioisosteres: influence upon vascular relaxation and soluble epoxide hydrolase inhibition. J. Med. Chem. 52, 5069-5075.
-
(2009)
J. Med. Chem.
, vol.52
, pp. 5069-5075
-
-
Falck, J.R.1
Kodela, R.2
Manne, R.3
Atcha, R.4
Puli, N.5
Dubasi, N.6
Manthati, V.L.7
Capdevila, J.H.8
Yi, X.Y.9
Goldman, D.H.10
Morisseau, C.11
Hammock, B.D.12
Campbell, W.B.13
-
4
-
-
0037232845
-
Comparison of vasodilatory properties of 14 15-EET analogs: structural requirements for dilation
-
Falck, J. R., Krishna, U. M., Reddy, Y. K., Kumar, P. S., Reddy, K. M., Hittner, S. B., Deeter, C., Sharma, K. K., Gauthier, K. M., and Campbell, W. B. (2003a). Comparison of vasodilatory properties of 14,15-EET analogs: structural requirements for dilation. Am. J. Physiol. Heart Circ. Physiol. 284, H337-H349.
-
(2003)
Am. J. Physiol. Heart Circ. Physiol.
, vol.284
-
-
Falck, J.R.1
Krishna, U.M.2
Reddy, Y.K.3
Kumar, P.S.4
Reddy, K.M.5
Hittner, S.B.6
Deeter, C.7
Sharma, K.K.8
Gauthier, K.M.9
Campbell, W.B.10
-
5
-
-
0242285600
-
11 12-epoxyeicosatrienoic acid (11 12-EET): structural determinants for inhibition of TNF-alpha-induced VCAM-1 expression
-
Falck, J. R., Reddy, L. M., Reddy, Y. K., Bondlela, M., Krishna, U. M., Ji, Y., Sun, J., and Liao, J. K. (2003b). 11,12-epoxyeicosatrienoic acid (11,12-EET): structural determinants for inhibition of TNF-alpha-induced VCAM-1 expression. Bioorg. Med. Chem. Lett. 13, 4011-4014.
-
(2003)
Bioorg. Med. Chem. Lett.
, vol.13
, pp. 4011-4014
-
-
Falck, J.R.1
Reddy, L.M.2
Reddy, Y.K.3
Bondlela, M.4
Krishna, U.M.5
Ji, Y.6
Sun, J.7
Liao, J.K.8
-
6
-
-
0033619262
-
Cytochrome P450 2C is an EDHF synthase in coronary arteries
-
Fisslthaler, B., Popp, R., Kiss, L., Potente, M., Harder, D. R., Fleming, I., and Busse, R. (1999). Cytochrome P450 2C is an EDHF synthase in coronary arteries. Nature 401, 493-497.
-
(1999)
Nature
, vol.401
, pp. 493-497
-
-
Fisslthaler, B.1
Popp, R.2
Kiss, L.3
Potente, M.4
Harder, D.R.5
Fleming, I.6
Busse, R.7
-
7
-
-
33845346159
-
Epoxyeicosatrienoic acids, cell signaling and angiogenesis
-
Fleming, I. (2007). Epoxyeicosatrienoic acids, cell signaling and angiogenesis. Prostaglandins Other Lipid Mediat. 82, 60-67.
-
(2007)
Prostaglandins Other Lipid Mediat
, vol.82
, pp. 60-67
-
-
Fleming, I.1
-
8
-
-
1542512379
-
14 15-EET analogs: characterization of structural requirements for agonist and antagonist activity in bovine coronary arteries
-
Gauthier, K. M., Falck, J. R., Reddy, L. M., and Campbell, W. B. (2004). 14,15-EET analogs: characterization of structural requirements for agonist and antagonist activity in bovine coronary arteries. Pharmacol. Res. 49, 515-524.
-
(2004)
Pharmacol. Res.
, vol.49
, pp. 515-524
-
-
Gauthier, K.M.1
Falck, J.R.2
Reddy, L.M.3
Campbell, W.B.4
-
9
-
-
49249116223
-
Effects of the selective EET antagonist 14 15-EEZE, on cardioprotection produced by exogenous or endogenous EETs in the canine heart
-
Gross, G. J., Gauthier, K. M., Moore, J., Falck, J. R., Hammock, B. D., Campbell, W. B., and Nithipatikom, K. (2008). Effects of the selective EET antagonist, 14,15-EEZE, on cardioprotection produced by exogenous or endogenous EETs in the canine heart. Am. J. Physiol. Heart Circ. Physiol. 294, H2838-H2844.
-
(2008)
Am. J. Physiol. Heart Circ. Physiol.
, vol.294
-
-
Gross, G.J.1
Gauthier, K.M.2
Moore, J.3
Falck, J.R.4
Hammock, B.D.5
Campbell, W.B.6
Nithipatikom, K.7
-
10
-
-
58849084528
-
Interaction between P450 eicosanoids and nitric oxide in the control of arterial tone in mice
-
Hercule, H. C., Schunck, W. H., Gross, V., Seringer, J., Leung, F. P., Weldon, S. M., da Costa Gonclalves, A. C. H., Huand, Y., Luft, F. C., and Gollasch, M. (2009). Interaction between P450 eicosanoids and nitric oxide in the control of arterial tone in mice. Aterioscler. Thromb. Vasc. Biol. 29, 54-60.
-
(2009)
Aterioscler. Thromb. Vasc. Biol.
, vol.29
, pp. 54-60
-
-
Hercule, H.C.1
Schunck, W.H.2
Gross, V.3
Seringer, J.4
Leung, F.P.5
Weldon, S.M.6
da Costa Gonclalves, A.C.H.7
Huand, Y.8
Luft, F.C.9
Gollasch, M.10
-
11
-
-
23944460748
-
Epoxide hydrolase and epoxygenase metabolites as therapeutic targets for renal diseases
-
Imig, J. D. (2005). Epoxide hydrolase and epoxygenase metabolites as therapeutic targets for renal diseases. Am. J. Physiol. Renal Physiol. 289, F496-F503.
-
(2005)
Am. J. Physiol. Renal Physiol.
, vol.289
-
-
Imig, J.D.1
-
12
-
-
38949115541
-
2 + -activated K + Channels
-
Imig, J. D., Dimitropoulou, C., Reddy, D. S., White, R. E., and Falck, J. R. (2008). Afferent arteriolar dilation to 11, 12-EET analogs involves PP2A activity and Ca2 + -activated K + Channels. Microcirculation 15, 137-150.
-
(2008)
Microcirculation
, vol.15
, pp. 137-150
-
-
Imig, J.D.1
Dimitropoulou, C.2
Reddy, D.S.3
White, R.E.4
Falck, J.R.5
-
13
-
-
77958487000
-
Compositions and methods for the treatment of renal and cardiovascular disease
-
Cont.-in-part of U.S. Ser. No. 866 395. US 2008153889 A1 20080626 CAN 149 104528 AN 2008 773879
-
Imig, J. D., and Falck, J. R. (2008a). Compositions and methods for the treatment of renal and cardiovascular disease. U.S. Pat. Appl. Publ., Cont.-in-part of U.S. Ser. No. 866,395. US 2008153889 A1 20080626 CAN 149:104528 AN 2008:773879.
-
(2008)
U. S. Pat. Appl. Publ.
-
-
Imig, J.D.1
Falck, J.R.2
-
14
-
-
84866375679
-
11-Nonyloxyundec-8(Z)-enoic acid and derivatives for the treatment of renal and cardiovascular disease
-
US 2008146663 A1 20080619 CAN 149 70453 AN 2008 743378
-
Imig, J. D., and Falck, J. R. (2008b). 11-Nonyloxyundec-8(Z)-enoic acid and derivatives for the treatment of renal and cardiovascular disease. U.S. Pat. Appl. Publ. US 2008146663 A1 20080619 CAN 149:70453 AN 2008:743378.
-
(2008)
U. S. Pat. Appl. Publ.
-
-
Imig, J.D.1
Falck, J.R.2
-
15
-
-
77958487000
-
Compositions and methods for the treatment of renal and cardiovascular disease
-
Imig, J. D., and Falck, J. R. (2009). Compositions and methods for the treatment of renal and cardiovascular disease. US Patent #7,550,617.
-
(2009)
US Patent
, vol.7
, Issue.550
, pp. 617
-
-
Imig, J.D.1
Falck, J.R.2
-
16
-
-
0032942665
-
Afferent arteriolar vasodilation to the sulfonimide analog of 11 12-epoxyeicosatrienoic acid involves protein kinase A
-
Imig, J. D., Inscho, E. W., Deichmann, P. C., Reddy, K. M., and Falck, J. R. (1999). Afferent arteriolar vasodilation to the sulfonimide analog of 11, 12-epoxyeicosatrienoic acid involves protein kinase A. Hypertension 33, 408-413.
-
(1999)
Hypertension
, vol.33
, pp. 408-413
-
-
Imig, J.D.1
Inscho, E.W.2
Deichmann, P.C.3
Reddy, K.M.4
Falck, J.R.5
-
17
-
-
0035024260
-
Enhanced renal microvascular reactivity to angiotensin II in hypertension is ameliorated by the sulfonimide analog of 11 12-epoxyeicosatrienoic acid
-
Imig, J. D., Zhao, X., Falck, J. R., Wei, S., and Capdevila, J. H. (2001). Enhanced renal microvascular reactivity to angiotensin II in hypertension is ameliorated by the sulfonimide analog of 11,12-epoxyeicosatrienoic acid. J. Hypertens. 19, 983-992.
-
(2001)
J. Hypertens.
, vol.19
, pp. 983-992
-
-
Imig, J.D.1
Zhao, X.2
Falck, J.R.3
Wei, S.4
Capdevila, J.H.5
-
18
-
-
33644654633
-
An orally active epoxide hydrolase inhibitor lowers blood pressure and provides renal protection in saltsensitive hypertension
-
Imig, J. D., Zhao, X., Zaharis, C. Z., Olearczyk, J. J., Pollock, D. M., Newman, J. W., Kim, I. H., Watanabe, T., and Hammock, B. D. (2005). An orally active epoxide hydrolase inhibitor lowers blood pressure and provides renal protection in saltsensitive hypertension. Hypertension 46, 975-981.
-
(2005)
Hypertension
, vol.46
, pp. 975-981
-
-
Imig, J.D.1
Zhao, X.2
Zaharis, C.Z.3
Olearczyk, J.J.4
Pollock, D.M.5
Newman, J.W.6
Kim, I.H.7
Watanabe, T.8
Hammock, B.D.9
-
19
-
-
1542343991
-
Membrane-potential-dependent inhibition of platelet adhesion to endothelial cells by epoxyeicosatrienoic acids
-
Krotz, F., Riexinger, T., Buerkle, M. A., Nithipatikom, K., Gloe, T., Sohn, H. Y., Campbell, W. B., and Pohl, U. (2004). Membrane-potential-dependent inhibition of platelet adhesion to endothelial cells by epoxyeicosatrienoic acids. Arterioscler. Thromb. Vasc. Biol. 24, 595-600.
-
(2004)
Arterioscler. Thromb. Vasc. Biol.
, vol.24
, pp. 595-600
-
-
Krotz, F.1
Riexinger, T.2
Buerkle, M.A.3
Nithipatikom, K.4
Gloe, T.5
Sohn, H.Y.6
Campbell, W.B.7
Pohl, U.8
-
20
-
-
0033588034
-
Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids
-
Node, K., Huo, Y., Ruan, X., Yang, B., Spiecker, M., Ley, K., Zeldin, D. C., and Liao, J. K. (1999). Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids. Science 285, 1276-1279.
-
(1999)
Science
, vol.285
, pp. 1276-1279
-
-
Node, K.1
Huo, Y.2
Ruan, X.3
Yang, B.4
Spiecker, M.5
Ley, K.6
Zeldin, D.C.7
Liao, J.K.8
-
21
-
-
0041529844
-
12-Epoxyeicosatrienoic acid-induced inhibition of FOXO factors promotes endothelial proliferation by downregulating p27Kip1
-
Potente, M., Fisslthaler, B., Busse, R., and Fleming, I. (2003). 11,12-Epoxyeicosatrienoic acid-induced inhibition of FOXO factors promotes endothelial proliferation by downregulating p27Kip1. J. Biol. Chem. 278, 29619-29625.
-
(2003)
J. Biol. Chem.
, vol.11
, pp. 29619-29625
-
-
Potente, M.1
Fisslthaler, B.2
Busse, R.3
Fleming, I.4
-
22
-
-
33845290283
-
Role of epoxyeicosatrienoic acids protecting the myocardium following ischemia/reperfusion injury
-
Seubert, J. M., Zeldin, D. C., Nithipatikom, K., and Gross, G. J. (2007). Role of epoxyeicosatrienoic acids protecting the myocardium following ischemia/reperfusion injury. Prostaglandins Other Lipid Mediat. 82, 50-59.
-
(2007)
Prostaglandins Other Lipid Mediat
, vol.82
, pp. 50-59
-
-
Seubert, J.M.1
Zeldin, D.C.2
Nithipatikom, K.3
Gross, G.J.4
-
23
-
-
73349106519
-
Epoxyeicosatrienoic acid agonist rescues metabolic syndrome phenotype of HO-2-null mice
-
Sodhi, K., Inoue, K., Gotlinger, K. H., Canestraro, M., Vanella, L., Kim, D. H., Manthati, V. L., Koduru, S. R., Falck, J. R., Schwarzman, M. L., and Abraham, N. G. (2009). Epoxyeicosatrienoic acid agonist rescues metabolic syndrome phenotype of HO-2-null mice. J. Pharmacol. Exp. Ther. 331, 906-916.
-
(2009)
J. Pharmacol. Exp. Ther.
, vol.331
, pp. 906-916
-
-
Sodhi, K.1
Inoue, K.2
Gotlinger, K.H.3
Canestraro, M.4
Vanella, L.5
Kim, D.H.6
Manthati, V.L.7
Koduru, S.R.8
Falck, J.R.9
Schwarzman, M.L.10
Abraham, N.G.11
-
24
-
-
0242720683
-
Epoxyeicosatrienoic acids (EETs): metabolism and biochemical function
-
Spector, A. A., Fang, X., Snyder, G. D., and Weintraub, N. L. (2004). Epoxyeicosatrienoic acids (EETs): metabolism and biochemical function. Prog. Lipid Res. 43, 55-90.
-
(2004)
Prog. Lipid Res.
, vol.43
, pp. 55-90
-
-
Spector, A.A.1
Fang, X.2
Snyder, G.D.3
Weintraub, N.L.4
-
25
-
-
77950679870
-
Epoxyeicosatrienoic acid analogs and vascular function
-
Sudhahar, V., Shaw, S., and Imig, J. D. (2010). Epoxyeicosatrienoic acid analogs and vascular function. Curr. Med. Chem. 17, 1181-1190.
-
(2010)
Curr. Med. Chem.
, vol.17
, pp. 1181-1190
-
-
Sudhahar, V.1
Shaw, S.2
Imig, J.D.3
-
26
-
-
0037123925
-
Inhibition of vascular smooth muscle cell migration by cytochrome p450 epoxygenase-derived eicosanoids
-
Sun, J., Sui, X., Bradbury, J. A., Zeldin, D. C., Conte, M. S., and Liao, J. K. (2002). Inhibition of vascular smooth muscle cell migration by cytochrome p450 epoxygenase-derived eicosanoids. Circ. Res. 90, 1020-1027.
-
(2002)
Circ. Res.
, vol.90
, pp. 1020-1027
-
-
Sun, J.1
Sui, X.2
Bradbury, J.A.3
Zeldin, D.C.4
Conte, M.S.5
Liao, J.K.6
-
27
-
-
0242721221
-
Effect of 11 12-epoxyeicosatrienoic acid as an additive to St. Thomas' cardioplegia and University of Wisconsin solutions on endothelium-derived hyperpolarizing factor-mediated function in coronary microarteries: influence of temperature and time
-
Yang, Q., Zhang, R. Z., Yim, A. P., and He, G. W. (2003). Effect of 11,12-epoxyeicosatrienoic acid as an additive to St. Thomas' cardioplegia and University of Wisconsin solutions on endothelium-derived hyperpolarizing factor-mediated function in coronary microarteries: influence of temperature and time. Ann. Thorac. Surg. 76, 1623-1630.
-
(2003)
Ann. Thorac. Surg.
, vol.76
, pp. 1623-1630
-
-
Yang, Q.1
Zhang, R.Z.2
Yim, A.P.3
He, G.W.4
-
28
-
-
34248570494
-
Characterization of 14,15-epoxyeicosatrienoyl-sulfonamides as 14 15-epoxyeicosatrienoic acid agonists: use for studies of metabolism and ligand binding
-
Yang, W., Holmes, B. B., Gopal, V. R., Kishore, R. V., Sangras, B., Yi, X. Y., Falck, J. R., and Campbell, W. B. (2007). Characterization of 14,15-epoxyeicosatrienoyl-sulfonamides as 14,15-epoxyeicosatrienoic acid agonists: use for studies of metabolism and ligand binding. J. Pharmacol. Exp. Ther. 321, 1023-1031.
-
(2007)
J. Pharmacol. Exp. Ther.
, vol.321
, pp. 1023-1031
-
-
Yang, W.1
Holmes, B.B.2
Gopal, V.R.3
Kishore, R.V.4
Sangras, B.5
Yi, X.Y.6
Falck, J.R.7
Campbell, W.B.8
-
29
-
-
0035965327
-
Epoxygenase pathways of arachidonic acid metabolism
-
Zeldin, D. C. (2001). Epoxygenase pathways of arachidonic acid metabolism. J. Biol. Chem. 276, 36059-36062.
-
(2001)
J. Biol. Chem.
, vol.276
, pp. 36059-36062
-
-
Zeldin, D.C.1
|